miércoles, 27 de diciembre de 2017

Drug Safety Labeling Changes (SLC)

U.S. Food and Drug Administration Header

Drug Safety Labeling Changes (SLC)

IMBRUVICA (NDA-205552)

(IBRUTINIB)
Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

No hay comentarios:

Publicar un comentario